The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2), PIK3CA wild-type advanced ...
(a, b) Construction and analysis of drug-disease targets; (c, d) GO and KEGG enrichment maps. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes. Ejiao can significantly improve the lung ...
Figure 1: Key signaling pathways and targeted factors in dysregulated BC. This figure illustrates the major signaling pathways and their intricate crosstalk in BC, focusing on the GPCR, RTKs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results